Verastem (VSTM) Stock Climbs On Amgen (AMGN) Collaboration

Verastem VSTM Stock News

Verastem Inc (NASDAQ: VSTM) is screaming for the top in the market this morning, and for good reason. The company said that it has entered into a clinical collaboration with Amgen (NASDAQ: AMGN) surrounding the development of a combination therapy for lung cancer. Here’s what’s going on: Stop wasting your time! Start finding winning trades … Read more

Verastem (VSTM) Stock: Rocketing On Collaboration And Earnings News

Yesterday, Verastem Inc (NASDAQ: VSTM) had an overwhelmingly strong trading session yesterday after announcing a collaboration. Those gains are continuing today after the company reported its financial results for the third quarter. Today, we’ll talk about: The financial results and the collaboration; what we’re seeing from VSTM stock; and what we’ll be wtching for ahead. … Read more

Verastem (VSTM) Stock: Headed Up On FDA Approval

Verastem Inc (NASDAQ: VSTM) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that the FDA has approved its New Drug Application for COPIKTRA™. Of course, the approval excited investors who are pushing the stock up in the market as we speak. Today, we’ll talk about: The … Read more

Verastem (VSTM) Stock: Headed Up On Clinical Data Presentation

Verastem Inc (NASDAQ: VSTM) is having an overwhelingly strong start to the trading session this morning, and for good reason. On Saturday, the company presented clinical data at the 23rd Congress of the European Hematology Association. With positive data presented, excited investors are reacting by sending the stock toward the top. Today, we’ll talk about: … Read more

Verastem (VSTM) Stock: Headed Up On Exclusive Licensing Agreement

Verastem Inc (NASDAQ: VSTM) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has entered into an exclusive license agreement just after presenting data at the 2018 ASCO Annual Meeting yesterday. With all of the good news, investors are excited, sending the stock … Read more